Evidence map›Paper›PMID 34903139›Full record

ArticleBioengineered2021

Downregulation of DEAD-box helicase 21 (DDX21) inhibits proliferation, cell cycle, and tumor growth in colorectal cancer via targeting cell division cycle 5-like (CDC5L).

Kai Wang, Baosong Li, Peng Fan, Xiang Ren, Hong Jiang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. LncRNA AC098613.1 promotes acute myeloid leukemia cell differentiation through CDC5L/ADAP1/NRD1 axis.Apoptosis : an international journal on programmed cell death · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kai WangDepartment of Colorectal and Anal Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, P.R. China.
Baosong LiDepartment of Colorectal and Anal Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, P.R. China.
Peng FanDepartment of Colorectal and Anal Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, P.R. China.
Xiang RenDepartment of Colorectal and Anal Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, P.R. China.
Hong JiangDepartment of Colorectal and Anal Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, P.R. China.
Binzhou University · CNBinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of novel anti-tumor target is crucial for cancer diagnosis, prognosis, and therapeutic strategy. The study aimed to explore the roles and interaction of DEAD-box helicase 21 (DDX21) and cell division cycle 5-like (CDC5L) in colorectal cancer (CRC) progression. Levels of DDX21 and CDC5L were detected in colorectal cancer cell lines by RT-qPCR and Western blot assay. The role of DDX21 and CDC5L on the cell proliferation, cell cycle and tumor growth were evaluated both

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCell CycleCell Cycle ProteinsCell Line, TumorCell ProliferationColorectal NeoplasmsDEAD-box RNA HelicasesDisease ProgressionDown-RegulationFemaleG2 PhaseGene SilencingHumansMiceMice, Inbred BALB CCDC5L protein, humanCell Cycle ProteinsDDX21 protein, humanDEAD-box RNA HelicasesRNA-Binding ProteinsCDC5Lcell cycle arrestcolorectal cancerDDX21proliferation

Identifiers

PMID34903139
PMCPMC8810101
OpenAlexW4200400657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.